nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Etoposide—prostate cancer	0.344	1	CrCtD
Podofilox—Teniposide—Etoposide—prostate cancer	0.193	1	CrCrCtD
Podofilox—TUBA4A—Cabazitaxel—prostate cancer	0.0961	0.427	CbGbCtD
Podofilox—TOP2A—prostate cancer	0.0643	0.405	CbGaD
Podofilox—NR3C1—prostate cancer	0.0379	0.239	CbGaD
Podofilox—TUBB—Cabazitaxel—prostate cancer	0.0367	0.163	CbGbCtD
Podofilox—CYP2C19—prostate cancer	0.0345	0.218	CbGaD
Podofilox—CYP3A4—prostate cancer	0.022	0.138	CbGaD
Podofilox—TUBB—Docetaxel—prostate cancer	0.0123	0.0547	CbGbCtD
Podofilox—TOP2A—Mitoxantrone—prostate cancer	0.0113	0.0505	CbGbCtD
Podofilox—TOP2A—Epirubicin—prostate cancer	0.00918	0.0408	CbGbCtD
Podofilox—TOP2A—Etoposide—prostate cancer	0.00715	0.0318	CbGbCtD
Podofilox—NR3C1—Prednisone—prostate cancer	0.00541	0.0241	CbGbCtD
Podofilox—CYP2C19—Bicalutamide—prostate cancer	0.00528	0.0235	CbGbCtD
Podofilox—CYP2C19—Nilutamide—prostate cancer	0.00528	0.0235	CbGbCtD
Podofilox—TOP2A—Doxorubicin—prostate cancer	0.00488	0.0217	CbGbCtD
Podofilox—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00486	0.0216	CbGbCtD
Podofilox—CYP2C19—Flutamide—prostate cancer	0.00437	0.0195	CbGbCtD
Podofilox—CYP3A4—Bicalutamide—prostate cancer	0.00255	0.0114	CbGbCtD
Podofilox—CYP3A4—Estramustine—prostate cancer	0.00237	0.0106	CbGbCtD
Podofilox—CYP3A4—Flutamide—prostate cancer	0.00211	0.0094	CbGbCtD
Podofilox—CYP3A4—Abiraterone—prostate cancer	0.00211	0.0094	CbGbCtD
Podofilox—CYP2C19—Estradiol—prostate cancer	0.00182	0.00808	CbGbCtD
Podofilox—CYP3A4—Cabazitaxel—prostate cancer	0.00156	0.00696	CbGbCtD
Podofilox—CYP2C19—Prednisone—prostate cancer	0.00156	0.00695	CbGbCtD
Podofilox—CYP3A4—Estrone—prostate cancer	0.00153	0.0068	CbGbCtD
Podofilox—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00136	0.00606	CbGbCtD
Podofilox—CYP2C19—urine—prostate cancer	0.00108	0.0836	CbGeAlD
Podofilox—CYP3A4—Conjugated Estrogens—prostate cancer	0.001	0.00445	CbGbCtD
Podofilox—CYP3A4—Mitoxantrone—prostate cancer	0.000909	0.00404	CbGbCtD
Podofilox—TUBA4A—prostate gland—prostate cancer	0.000891	0.069	CbGeAlD
Podofilox—CYP3A4—Estradiol—prostate cancer	0.000878	0.00391	CbGbCtD
Podofilox—NR3C1—urine—prostate cancer	0.000843	0.0653	CbGeAlD
Podofilox—CYP3A4—Prednisone—prostate cancer	0.000755	0.00336	CbGbCtD
Podofilox—TUBA4A—seminal vesicle—prostate cancer	0.000754	0.0584	CbGeAlD
Podofilox—Teniposide—NCOA1—prostate cancer	0.000718	0.335	CrCbGaD
Podofilox—TOP2A—prostate gland—prostate cancer	0.000659	0.0511	CbGeAlD
Podofilox—TUBA4A—epithelium—prostate cancer	0.000655	0.0507	CbGeAlD
Podofilox—TUBB—prostate gland—prostate cancer	0.000653	0.0506	CbGeAlD
Podofilox—CYP3A4—urine—prostate cancer	0.000637	0.0494	CbGeAlD
Podofilox—TUBA4A—renal system—prostate cancer	0.000607	0.0471	CbGeAlD
Podofilox—TUBA4A—urethra—prostate cancer	0.000596	0.0462	CbGeAlD
Podofilox—CYP3A4—Etoposide—prostate cancer	0.000573	0.00255	CbGbCtD
Podofilox—TUBB—seminal vesicle—prostate cancer	0.000552	0.0428	CbGeAlD
Podofilox—CYP3A4—Docetaxel—prostate cancer	0.000524	0.00233	CbGbCtD
Podofilox—Teniposide—NCOA3—prostate cancer	0.000485	0.226	CrCbGaD
Podofilox—TUBA4A—bone marrow—prostate cancer	0.000459	0.0356	CbGeAlD
Podofilox—TUBB—urethra—prostate cancer	0.000437	0.0339	CbGeAlD
Podofilox—TUBA4A—testis—prostate cancer	0.000392	0.0304	CbGeAlD
Podofilox—CYP3A4—Doxorubicin—prostate cancer	0.000391	0.00174	CbGbCtD
Podofilox—TOP2A—bone marrow—prostate cancer	0.00034	0.0263	CbGeAlD
Podofilox—TUBB—bone marrow—prostate cancer	0.000337	0.0261	CbGeAlD
Podofilox—NR3C1—prostate gland—prostate cancer	0.000303	0.0234	CbGeAlD
Podofilox—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000296	0.281	CbGdCrCtD
Podofilox—TOP2A—testis—prostate cancer	0.00029	0.0225	CbGeAlD
Podofilox—TUBB—testis—prostate cancer	0.000288	0.0223	CbGeAlD
Podofilox—TUBA4A—lymph node—prostate cancer	0.000284	0.022	CbGeAlD
Podofilox—NR3C1—seminal vesicle—prostate cancer	0.000256	0.0198	CbGeAlD
Podofilox—NR3C1—epithelium—prostate cancer	0.000222	0.0172	CbGeAlD
Podofilox—TOP2A—lymph node—prostate cancer	0.00021	0.0163	CbGeAlD
Podofilox—TUBB—lymph node—prostate cancer	0.000209	0.0162	CbGeAlD
Podofilox—NR3C1—renal system—prostate cancer	0.000206	0.016	CbGeAlD
Podofilox—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000204	0.194	CbGdCrCtD
Podofilox—NR3C1—urethra—prostate cancer	0.000203	0.0157	CbGeAlD
Podofilox—CYP3A4—renal system—prostate cancer	0.000156	0.0121	CbGeAlD
Podofilox—NR3C1—bone marrow—prostate cancer	0.000156	0.0121	CbGeAlD
Podofilox—Teniposide—TOP2A—prostate cancer	0.000141	0.0657	CrCbGaD
Podofilox—Etoposide—GSTT1—prostate cancer	0.00014	0.0652	CrCbGaD
Podofilox—NR3C1—testis—prostate cancer	0.000133	0.0103	CbGeAlD
Podofilox—Teniposide—CYP3A5—prostate cancer	0.000111	0.0519	CrCbGaD
Podofilox—Etoposide—GSTP1—prostate cancer	0.000111	0.0516	CrCbGaD
Podofilox—Etoposide—TOP2A—prostate cancer	0.000104	0.0487	CrCbGaD
Podofilox—Haematuria—Goserelin—prostate cancer	0.000103	0.00309	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.000103	0.00307	CcSEcCtD
Podofilox—Dry skin—Estradiol—prostate cancer	0.000102	0.00305	CcSEcCtD
Podofilox—Inflammation—Docetaxel—prostate cancer	0.000102	0.00304	CcSEcCtD
Podofilox—Ulcer—Capecitabine—prostate cancer	0.000101	0.00302	CcSEcCtD
Podofilox—Oedema—Bicalutamide—prostate cancer	9.94e-05	0.00297	CcSEcCtD
Podofilox—Pain—Cabazitaxel—prostate cancer	9.9e-05	0.00296	CcSEcCtD
Podofilox—Redness—Epirubicin—prostate cancer	9.88e-05	0.00295	CcSEcCtD
Podofilox—Inflammation—Capecitabine—prostate cancer	9.87e-05	0.00295	CcSEcCtD
Podofilox—Vomiting—Estramustine—prostate cancer	9.86e-05	0.00294	CcSEcCtD
Podofilox—Dizziness—Estrone—prostate cancer	9.8e-05	0.00293	CcSEcCtD
Podofilox—Swelling—Etoposide—prostate cancer	9.79e-05	0.00292	CcSEcCtD
Podofilox—Rash—Estramustine—prostate cancer	9.78e-05	0.00292	CcSEcCtD
Podofilox—Haemoglobin—Goserelin—prostate cancer	9.78e-05	0.00292	CcSEcCtD
Podofilox—Dermatitis—Estramustine—prostate cancer	9.77e-05	0.00292	CcSEcCtD
Podofilox—Pruritus—Nilutamide—prostate cancer	9.74e-05	0.00291	CcSEcCtD
Podofilox—Haemorrhage—Goserelin—prostate cancer	9.73e-05	0.0029	CcSEcCtD
Podofilox—Headache—Estramustine—prostate cancer	9.72e-05	0.0029	CcSEcCtD
Podofilox—Pruritus—Flutamide—prostate cancer	9.69e-05	0.00289	CcSEcCtD
Podofilox—NR3C1—lymph node—prostate cancer	9.66e-05	0.00749	CbGeAlD
Podofilox—Skin disorder—Bicalutamide—prostate cancer	9.65e-05	0.00288	CcSEcCtD
Podofilox—Vomiting—Abiraterone—prostate cancer	9.58e-05	0.00286	CcSEcCtD
Podofilox—Rash—Abiraterone—prostate cancer	9.5e-05	0.00284	CcSEcCtD
Podofilox—Dermatitis—Abiraterone—prostate cancer	9.49e-05	0.00283	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—prostate cancer	9.44e-05	0.00282	CcSEcCtD
Podofilox—Vomiting—Estrone—prostate cancer	9.42e-05	0.00281	CcSEcCtD
Podofilox—Rash—Estrone—prostate cancer	9.34e-05	0.00279	CcSEcCtD
Podofilox—Dermatitis—Estrone—prostate cancer	9.33e-05	0.00279	CcSEcCtD
Podofilox—Headache—Estrone—prostate cancer	9.28e-05	0.00277	CcSEcCtD
Podofilox—Blister—Epirubicin—prostate cancer	9.26e-05	0.00276	CcSEcCtD
Podofilox—Pruritus—Estradiol valerate/Dienogest—prostate cancer	9.15e-05	0.00273	CcSEcCtD
Podofilox—Redness—Doxorubicin—prostate cancer	9.15e-05	0.00273	CcSEcCtD
Podofilox—Skin exfoliation—Capecitabine—prostate cancer	9.14e-05	0.00273	CcSEcCtD
Podofilox—Dizziness—Nilutamide—prostate cancer	9.1e-05	0.00272	CcSEcCtD
Podofilox—Dizziness—Flutamide—prostate cancer	9.06e-05	0.00271	CcSEcCtD
Podofilox—Ulcer—Prednisone—prostate cancer	9.02e-05	0.00269	CcSEcCtD
Podofilox—Insomnia—Bicalutamide—prostate cancer	8.99e-05	0.00268	CcSEcCtD
Podofilox—Paraesthesia—Bicalutamide—prostate cancer	8.92e-05	0.00266	CcSEcCtD
Podofilox—Immune system disorder—Goserelin—prostate cancer	8.79e-05	0.00262	CcSEcCtD
Podofilox—Vomiting—Nilutamide—prostate cancer	8.75e-05	0.00261	CcSEcCtD
Podofilox—Vomiting—Flutamide—prostate cancer	8.71e-05	0.0026	CcSEcCtD
Podofilox—Immune system disorder—Conjugated Estrogens—prostate cancer	8.7e-05	0.0026	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	8.7e-05	0.0026	CcSEcCtD
Podofilox—Pruritus—Degarelix—prostate cancer	8.7e-05	0.0026	CcSEcCtD
Podofilox—Rash—Nilutamide—prostate cancer	8.68e-05	0.00259	CcSEcCtD
Podofilox—Dermatitis—Nilutamide—prostate cancer	8.67e-05	0.00259	CcSEcCtD
Podofilox—Rash—Flutamide—prostate cancer	8.64e-05	0.00258	CcSEcCtD
Podofilox—Dermatitis—Flutamide—prostate cancer	8.63e-05	0.00258	CcSEcCtD
Podofilox—Headache—Nilutamide—prostate cancer	8.62e-05	0.00257	CcSEcCtD
Podofilox—Headache—Flutamide—prostate cancer	8.58e-05	0.00256	CcSEcCtD
Podofilox—Skin ulcer—Epirubicin—prostate cancer	8.57e-05	0.00256	CcSEcCtD
Podofilox—Blister—Doxorubicin—prostate cancer	8.57e-05	0.00256	CcSEcCtD
Podofilox—Dizziness—Estradiol valerate/Dienogest—prostate cancer	8.55e-05	0.00255	CcSEcCtD
Podofilox—Pain—Bicalutamide—prostate cancer	8.5e-05	0.00254	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—prostate cancer	8.48e-05	0.0804	CbGdCrCtD
Podofilox—Erythema—Goserelin—prostate cancer	8.47e-05	0.00253	CcSEcCtD
Podofilox—Oedema—Ethinyl Estradiol—prostate cancer	8.4e-05	0.00251	CcSEcCtD
Podofilox—Erythema—Conjugated Estrogens—prostate cancer	8.39e-05	0.0025	CcSEcCtD
Podofilox—Etoposide—CYP3A5—prostate cancer	8.25e-05	0.0385	CrCbGaD
Podofilox—Stinging—Epirubicin—prostate cancer	8.24e-05	0.00246	CcSEcCtD
Podofilox—Vomiting—Estradiol valerate/Dienogest—prostate cancer	8.22e-05	0.00246	CcSEcCtD
Podofilox—Haematuria—Estradiol—prostate cancer	8.19e-05	0.00245	CcSEcCtD
Podofilox—Skin disorder—Ethinyl Estradiol—prostate cancer	8.16e-05	0.00244	CcSEcCtD
Podofilox—Rash—Estradiol valerate/Dienogest—prostate cancer	8.15e-05	0.00243	CcSEcCtD
Podofilox—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	8.15e-05	0.00243	CcSEcCtD
Podofilox—Skin exfoliation—Prednisone—prostate cancer	8.14e-05	0.00243	CcSEcCtD
Podofilox—Swelling—Docetaxel—prostate cancer	8.14e-05	0.00243	CcSEcCtD
Podofilox—Dizziness—Degarelix—prostate cancer	8.13e-05	0.00243	CcSEcCtD
Podofilox—Headache—Estradiol valerate/Dienogest—prostate cancer	8.1e-05	0.00242	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—prostate cancer	7.93e-05	0.00237	CcSEcCtD
Podofilox—Swelling—Capecitabine—prostate cancer	7.88e-05	0.00235	CcSEcCtD
Podofilox—Vomiting—Degarelix—prostate cancer	7.82e-05	0.00233	CcSEcCtD
Podofilox—Rash—Degarelix—prostate cancer	7.75e-05	0.00231	CcSEcCtD
Podofilox—Haemoglobin—Estradiol—prostate cancer	7.75e-05	0.00231	CcSEcCtD
Podofilox—Dermatitis—Degarelix—prostate cancer	7.75e-05	0.00231	CcSEcCtD
Podofilox—Haemorrhage—Estradiol—prostate cancer	7.71e-05	0.0023	CcSEcCtD
Podofilox—Headache—Degarelix—prostate cancer	7.7e-05	0.0023	CcSEcCtD
Podofilox—Dizziness—Cabazitaxel—prostate cancer	7.66e-05	0.00229	CcSEcCtD
Podofilox—Haematuria—Mitoxantrone—prostate cancer	7.63e-05	0.00228	CcSEcCtD
Podofilox—Stinging—Doxorubicin—prostate cancer	7.62e-05	0.00228	CcSEcCtD
Podofilox—Teniposide—CYP2C19—prostate cancer	7.57e-05	0.0353	CrCbGaD
Podofilox—Dermatitis bullous—Docetaxel—prostate cancer	7.51e-05	0.00224	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—prostate cancer	7.39e-05	0.00221	CcSEcCtD
Podofilox—Vomiting—Cabazitaxel—prostate cancer	7.36e-05	0.0022	CcSEcCtD
Podofilox—Dermatitis bullous—Capecitabine—prostate cancer	7.27e-05	0.00217	CcSEcCtD
Podofilox—Headache—Cabazitaxel—prostate cancer	7.26e-05	0.00217	CcSEcCtD
Podofilox—Haemoglobin—Mitoxantrone—prostate cancer	7.22e-05	0.00216	CcSEcCtD
Podofilox—Haemorrhage—Mitoxantrone—prostate cancer	7.19e-05	0.00215	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	7.16e-05	0.00214	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	7.09e-05	0.00212	CcSEcCtD
Podofilox—Ulcer—Epirubicin—prostate cancer	7.05e-05	0.00211	CcSEcCtD
Podofilox—Pruritus—Bicalutamide—prostate cancer	7.03e-05	0.0021	CcSEcCtD
Podofilox—Immune system disorder—Estradiol—prostate cancer	6.97e-05	0.00208	CcSEcCtD
Podofilox—Oedema—Goserelin—prostate cancer	6.91e-05	0.00206	CcSEcCtD
Podofilox—Inflammation—Epirubicin—prostate cancer	6.88e-05	0.00205	CcSEcCtD
Podofilox—Oedema—Conjugated Estrogens—prostate cancer	6.85e-05	0.00204	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—prostate cancer	6.83e-05	0.00204	CcSEcCtD
Podofilox—Erythema—Estradiol—prostate cancer	6.71e-05	0.002	CcSEcCtD
Podofilox—Skin disorder—Goserelin—prostate cancer	6.71e-05	0.002	CcSEcCtD
Podofilox—Skin disorder—Conjugated Estrogens—prostate cancer	6.65e-05	0.00199	CcSEcCtD
Podofilox—Dry skin—Docetaxel—prostate cancer	6.58e-05	0.00197	CcSEcCtD
Podofilox—Dizziness—Bicalutamide—prostate cancer	6.57e-05	0.00196	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—prostate cancer	6.53e-05	0.00195	CcSEcCtD
Podofilox—Dry skin—Capecitabine—prostate cancer	6.37e-05	0.0019	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—prostate cancer	6.37e-05	0.0019	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—prostate cancer	6.36e-05	0.0019	CcSEcCtD
Podofilox—Vomiting—Bicalutamide—prostate cancer	6.32e-05	0.00189	CcSEcCtD
Podofilox—Rash—Bicalutamide—prostate cancer	6.26e-05	0.00187	CcSEcCtD
Podofilox—Dermatitis—Bicalutamide—prostate cancer	6.26e-05	0.00187	CcSEcCtD
Podofilox—Erythema—Mitoxantrone—prostate cancer	6.26e-05	0.00187	CcSEcCtD
Podofilox—Insomnia—Goserelin—prostate cancer	6.25e-05	0.00187	CcSEcCtD
Podofilox—Headache—Bicalutamide—prostate cancer	6.22e-05	0.00186	CcSEcCtD
Podofilox—Paraesthesia—Goserelin—prostate cancer	6.21e-05	0.00185	CcSEcCtD
Podofilox—Insomnia—Conjugated Estrogens—prostate cancer	6.19e-05	0.00185	CcSEcCtD
Podofilox—TOP2A—Fulvestrant—Estradiol—prostate cancer	6.19e-05	0.0587	CbGdCrCtD
Podofilox—Paraesthesia—Conjugated Estrogens—prostate cancer	6.15e-05	0.00184	CcSEcCtD
Podofilox—Pruritus—Ethinyl Estradiol—prostate cancer	5.94e-05	0.00177	CcSEcCtD
Podofilox—Pain—Goserelin—prostate cancer	5.91e-05	0.00176	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—prostate cancer	5.89e-05	0.00176	CcSEcCtD
Podofilox—Pain—Conjugated Estrogens—prostate cancer	5.85e-05	0.00175	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	5.68e-05	0.00169	CcSEcCtD
Podofilox—Dry skin—Prednisone—prostate cancer	5.68e-05	0.00169	CcSEcCtD
Podofilox—Etoposide—CYP2E1—prostate cancer	5.67e-05	0.0264	CrCbGaD
Podofilox—Dizziness—Ethinyl Estradiol—prostate cancer	5.55e-05	0.00166	CcSEcCtD
Podofilox—Oedema—Estradiol—prostate cancer	5.48e-05	0.00164	CcSEcCtD
Podofilox—TOP2A—Teniposide—Etoposide—prostate cancer	5.45e-05	0.0517	CbGdCrCtD
Podofilox—Immune system disorder—Etoposide—prostate cancer	5.4e-05	0.00161	CcSEcCtD
Podofilox—TOP2A—Levorphanol—Estrone—prostate cancer	5.39e-05	0.0512	CbGdCrCtD
Podofilox—Vomiting—Ethinyl Estradiol—prostate cancer	5.34e-05	0.00159	CcSEcCtD
Podofilox—Skin disorder—Estradiol—prostate cancer	5.32e-05	0.00159	CcSEcCtD
Podofilox—Rash—Ethinyl Estradiol—prostate cancer	5.3e-05	0.00158	CcSEcCtD
Podofilox—Dermatitis—Ethinyl Estradiol—prostate cancer	5.29e-05	0.00158	CcSEcCtD
Podofilox—Headache—Ethinyl Estradiol—prostate cancer	5.26e-05	0.00157	CcSEcCtD
Podofilox—Haematuria—Capecitabine—prostate cancer	5.11e-05	0.00153	CcSEcCtD
Podofilox—Oedema—Mitoxantrone—prostate cancer	5.11e-05	0.00152	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—prostate cancer	5.07e-05	0.00151	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—prostate cancer	4.99e-05	0.00149	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—prostate cancer	4.97e-05	0.00148	CcSEcCtD
Podofilox—Skin disorder—Mitoxantrone—prostate cancer	4.96e-05	0.00148	CcSEcCtD
Podofilox—Insomnia—Estradiol—prostate cancer	4.96e-05	0.00148	CcSEcCtD
Podofilox—Paraesthesia—Estradiol—prostate cancer	4.92e-05	0.00147	CcSEcCtD
Podofilox—Pruritus—Goserelin—prostate cancer	4.89e-05	0.00146	CcSEcCtD
Podofilox—Pruritus—Conjugated Estrogens—prostate cancer	4.84e-05	0.00145	CcSEcCtD
Podofilox—Haemoglobin—Capecitabine—prostate cancer	4.83e-05	0.00144	CcSEcCtD
Podofilox—Teniposide—CYP3A4—prostate cancer	4.81e-05	0.0225	CrCbGaD
Podofilox—Haemorrhage—Capecitabine—prostate cancer	4.81e-05	0.00144	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—prostate cancer	4.69e-05	0.0014	CcSEcCtD
Podofilox—Pain—Estradiol—prostate cancer	4.69e-05	0.0014	CcSEcCtD
Podofilox—Paraesthesia—Mitoxantrone—prostate cancer	4.58e-05	0.00137	CcSEcCtD
Podofilox—Dizziness—Goserelin—prostate cancer	4.57e-05	0.00136	CcSEcCtD
Podofilox—Dizziness—Conjugated Estrogens—prostate cancer	4.53e-05	0.00135	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—prostate cancer	4.49e-05	0.00134	CcSEcCtD
Podofilox—Dry skin—Epirubicin—prostate cancer	4.44e-05	0.00133	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	4.4e-05	0.00131	CcSEcCtD
Podofilox—Vomiting—Goserelin—prostate cancer	4.39e-05	0.00131	CcSEcCtD
Podofilox—Pain—Mitoxantrone—prostate cancer	4.37e-05	0.0013	CcSEcCtD
Podofilox—Rash—Goserelin—prostate cancer	4.36e-05	0.0013	CcSEcCtD
Podofilox—Dermatitis—Goserelin—prostate cancer	4.35e-05	0.0013	CcSEcCtD
Podofilox—Vomiting—Conjugated Estrogens—prostate cancer	4.35e-05	0.0013	CcSEcCtD
Podofilox—Immune system disorder—Capecitabine—prostate cancer	4.34e-05	0.0013	CcSEcCtD
Podofilox—Headache—Goserelin—prostate cancer	4.33e-05	0.00129	CcSEcCtD
Podofilox—Erythema—Docetaxel—prostate cancer	4.32e-05	0.00129	CcSEcCtD
Podofilox—Rash—Conjugated Estrogens—prostate cancer	4.32e-05	0.00129	CcSEcCtD
Podofilox—Dermatitis—Conjugated Estrogens—prostate cancer	4.31e-05	0.00129	CcSEcCtD
Podofilox—Haemoglobin—Prednisone—prostate cancer	4.31e-05	0.00129	CcSEcCtD
Podofilox—Headache—Conjugated Estrogens—prostate cancer	4.29e-05	0.00128	CcSEcCtD
Podofilox—Haemorrhage—Prednisone—prostate cancer	4.28e-05	0.00128	CcSEcCtD
Podofilox—Erythema—Capecitabine—prostate cancer	4.19e-05	0.00125	CcSEcCtD
Podofilox—Skin disorder—Etoposide—prostate cancer	4.12e-05	0.00123	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—prostate cancer	4.11e-05	0.00123	CcSEcCtD
Podofilox—TOP2A—Levorphanol—Estradiol—prostate cancer	4.09e-05	0.0388	CbGdCrCtD
Podofilox—Pruritus—Estradiol—prostate cancer	3.88e-05	0.00116	CcSEcCtD
Podofilox—Immune system disorder—Prednisone—prostate cancer	3.87e-05	0.00116	CcSEcCtD
Podofilox—Paraesthesia—Etoposide—prostate cancer	3.81e-05	0.00114	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	3.73e-05	0.0354	CbGdCrCtD
Podofilox—Erythema—Prednisone—prostate cancer	3.73e-05	0.00111	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	3.66e-05	0.00109	CcSEcCtD
Podofilox—Pain—Etoposide—prostate cancer	3.63e-05	0.00108	CcSEcCtD
Podofilox—Dizziness—Estradiol—prostate cancer	3.62e-05	0.00108	CcSEcCtD
Podofilox—Etoposide—CYP3A4—prostate cancer	3.57e-05	0.0167	CrCbGaD
Podofilox—Haematuria—Epirubicin—prostate cancer	3.56e-05	0.00106	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.54e-05	0.00106	CcSEcCtD
Podofilox—Oedema—Docetaxel—prostate cancer	3.53e-05	0.00105	CcSEcCtD
Podofilox—Etoposide—PTGS2—prostate cancer	3.5e-05	0.0163	CrCbGaD
Podofilox—Vomiting—Estradiol—prostate cancer	3.48e-05	0.00104	CcSEcCtD
Podofilox—Rash—Estradiol—prostate cancer	3.45e-05	0.00103	CcSEcCtD
Podofilox—Dermatitis—Estradiol—prostate cancer	3.45e-05	0.00103	CcSEcCtD
Podofilox—Headache—Estradiol—prostate cancer	3.43e-05	0.00102	CcSEcCtD
Podofilox—Skin disorder—Docetaxel—prostate cancer	3.43e-05	0.00102	CcSEcCtD
Podofilox—Oedema—Capecitabine—prostate cancer	3.42e-05	0.00102	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—prostate cancer	3.37e-05	0.00101	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—prostate cancer	3.35e-05	0.001	CcSEcCtD
Podofilox—Skin disorder—Capecitabine—prostate cancer	3.32e-05	0.000991	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—prostate cancer	3.29e-05	0.000983	CcSEcCtD
Podofilox—Vomiting—Mitoxantrone—prostate cancer	3.25e-05	0.000969	CcSEcCtD
Podofilox—Rash—Mitoxantrone—prostate cancer	3.22e-05	0.000961	CcSEcCtD
Podofilox—Dermatitis—Mitoxantrone—prostate cancer	3.22e-05	0.00096	CcSEcCtD
Podofilox—Headache—Mitoxantrone—prostate cancer	3.2e-05	0.000955	CcSEcCtD
Podofilox—Insomnia—Docetaxel—prostate cancer	3.19e-05	0.000953	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—prostate cancer	3.17e-05	0.000946	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.15e-05	0.000941	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—prostate cancer	3.12e-05	0.00093	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—prostate cancer	3.1e-05	0.000926	CcSEcCtD
Podofilox—Insomnia—Capecitabine—prostate cancer	3.09e-05	0.000923	CcSEcCtD
Podofilox—Paraesthesia—Capecitabine—prostate cancer	3.07e-05	0.000916	CcSEcCtD
Podofilox—Oedema—Prednisone—prostate cancer	3.04e-05	0.000909	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—prostate cancer	3.03e-05	0.000904	CcSEcCtD
Podofilox—Pain—Docetaxel—prostate cancer	3.02e-05	0.000901	CcSEcCtD
Podofilox—Pruritus—Etoposide—prostate cancer	3e-05	0.000897	CcSEcCtD
Podofilox—Skin disorder—Prednisone—prostate cancer	2.96e-05	0.000883	CcSEcCtD
Podofilox—Pain—Capecitabine—prostate cancer	2.92e-05	0.000872	CcSEcCtD
Podofilox—Erythema—Epirubicin—prostate cancer	2.92e-05	0.000871	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—prostate cancer	2.84e-05	0.0269	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—prostate cancer	2.84e-05	0.0269	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—prostate cancer	2.84e-05	0.0269	CbGdCrCtD
Podofilox—Dizziness—Etoposide—prostate cancer	2.81e-05	0.000838	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—prostate cancer	2.8e-05	0.000836	CcSEcCtD
Podofilox—Insomnia—Prednisone—prostate cancer	2.75e-05	0.000822	CcSEcCtD
Podofilox—Paraesthesia—Prednisone—prostate cancer	2.73e-05	0.000816	CcSEcCtD
Podofilox—Vomiting—Etoposide—prostate cancer	2.7e-05	0.000806	CcSEcCtD
Podofilox—Erythema—Doxorubicin—prostate cancer	2.7e-05	0.000806	CcSEcCtD
Podofilox—Rash—Etoposide—prostate cancer	2.68e-05	0.000799	CcSEcCtD
Podofilox—Dermatitis—Etoposide—prostate cancer	2.68e-05	0.000799	CcSEcCtD
Podofilox—Headache—Etoposide—prostate cancer	2.66e-05	0.000794	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—prostate cancer	2.63e-05	0.0249	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—prostate cancer	2.63e-05	0.0249	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	2.63e-05	0.0249	CbGdCrCtD
Podofilox—Pruritus—Docetaxel—prostate cancer	2.5e-05	0.000746	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.47e-05	0.000736	CcSEcCtD
Podofilox—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	2.43e-05	0.0231	CbGdCrCtD
Podofilox—Pruritus—Capecitabine—prostate cancer	2.42e-05	0.000722	CcSEcCtD
Podofilox—Oedema—Epirubicin—prostate cancer	2.38e-05	0.000711	CcSEcCtD
Podofilox—Dizziness—Docetaxel—prostate cancer	2.33e-05	0.000697	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—prostate cancer	2.31e-05	0.00069	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.28e-05	0.000681	CcSEcCtD
Podofilox—Dizziness—Capecitabine—prostate cancer	2.26e-05	0.000675	CcSEcCtD
Podofilox—Vomiting—Docetaxel—prostate cancer	2.24e-05	0.00067	CcSEcCtD
Podofilox—Rash—Docetaxel—prostate cancer	2.23e-05	0.000664	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—prostate cancer	2.22e-05	0.000664	CcSEcCtD
Podofilox—Headache—Docetaxel—prostate cancer	2.21e-05	0.00066	CcSEcCtD
Podofilox—Oedema—Doxorubicin—prostate cancer	2.2e-05	0.000658	CcSEcCtD
Podofilox—Vomiting—Capecitabine—prostate cancer	2.17e-05	0.000649	CcSEcCtD
Podofilox—Rash—Capecitabine—prostate cancer	2.15e-05	0.000643	CcSEcCtD
Podofilox—Pruritus—Prednisone—prostate cancer	2.15e-05	0.000643	CcSEcCtD
Podofilox—Insomnia—Epirubicin—prostate cancer	2.15e-05	0.000643	CcSEcCtD
Podofilox—Dermatitis—Capecitabine—prostate cancer	2.15e-05	0.000643	CcSEcCtD
Podofilox—Headache—Capecitabine—prostate cancer	2.14e-05	0.000639	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—prostate cancer	2.14e-05	0.000639	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—prostate cancer	2.14e-05	0.000638	CcSEcCtD
Podofilox—Pain—Epirubicin—prostate cancer	2.04e-05	0.000608	CcSEcCtD
Podofilox—Dizziness—Prednisone—prostate cancer	2.01e-05	0.000601	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—prostate cancer	1.99e-05	0.000595	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—prostate cancer	1.98e-05	0.000591	CcSEcCtD
Podofilox—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	1.94e-05	0.0184	CbGdCrCtD
Podofilox—Vomiting—Prednisone—prostate cancer	1.94e-05	0.000578	CcSEcCtD
Podofilox—Rash—Prednisone—prostate cancer	1.92e-05	0.000573	CcSEcCtD
Podofilox—Dermatitis—Prednisone—prostate cancer	1.92e-05	0.000572	CcSEcCtD
Podofilox—Headache—Prednisone—prostate cancer	1.91e-05	0.000569	CcSEcCtD
Podofilox—Pain—Doxorubicin—prostate cancer	1.88e-05	0.000562	CcSEcCtD
Podofilox—Pruritus—Epirubicin—prostate cancer	1.68e-05	0.000503	CcSEcCtD
Podofilox—Dizziness—Epirubicin—prostate cancer	1.57e-05	0.00047	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—prostate cancer	1.56e-05	0.000465	CcSEcCtD
Podofilox—Vomiting—Epirubicin—prostate cancer	1.51e-05	0.000452	CcSEcCtD
Podofilox—Rash—Epirubicin—prostate cancer	1.5e-05	0.000448	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—prostate cancer	1.5e-05	0.000448	CcSEcCtD
Podofilox—Headache—Epirubicin—prostate cancer	1.49e-05	0.000445	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—prostate cancer	1.46e-05	0.000435	CcSEcCtD
Podofilox—Vomiting—Doxorubicin—prostate cancer	1.4e-05	0.000418	CcSEcCtD
Podofilox—Rash—Doxorubicin—prostate cancer	1.39e-05	0.000415	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—prostate cancer	1.39e-05	0.000414	CcSEcCtD
Podofilox—Headache—Doxorubicin—prostate cancer	1.38e-05	0.000412	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Prednisone—prostate cancer	1.31e-05	0.0124	CbGdCrCtD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	4.17e-06	0.000141	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	4.16e-06	0.000141	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	4.15e-06	0.00014	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	4.13e-06	0.00014	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP3A43—prostate cancer	4.05e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AMACR—prostate cancer	4.05e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SRD5A2—prostate cancer	4.05e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DEGS1—prostate cancer	4.05e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAT1—prostate cancer	4.05e-06	0.000137	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—prostate cancer	4.03e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.98e-06	0.000134	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	3.96e-06	0.000134	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	3.86e-06	0.00013	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPS19—prostate cancer	3.86e-06	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD17B1—prostate cancer	3.86e-06	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.86e-06	0.00013	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—prostate cancer	3.85e-06	0.00013	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—prostate cancer	3.85e-06	0.00013	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—prostate cancer	3.81e-06	0.000129	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	3.8e-06	0.000128	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—prostate cancer	3.72e-06	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.71e-06	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.69e-06	0.000125	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DNMT1—prostate cancer	3.69e-06	0.000125	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	3.66e-06	0.000124	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.65e-06	0.000123	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	3.65e-06	0.000123	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—prostate cancer	3.62e-06	0.000122	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOA2—prostate cancer	3.62e-06	0.000122	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HAO1—prostate cancer	3.6e-06	0.000122	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	3.6e-06	0.000122	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EZH2—prostate cancer	3.57e-06	0.000121	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—EP300—prostate cancer	3.54e-06	0.00012	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PARP1—prostate cancer	3.5e-06	0.000118	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.48e-06	0.000118	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	3.45e-06	0.000117	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPGD—prostate cancer	3.44e-06	0.000116	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—B4GALT4—prostate cancer	3.44e-06	0.000116	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	3.43e-06	0.000116	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1A—prostate cancer	3.31e-06	0.000112	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR2—prostate cancer	3.31e-06	0.000112	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TNFRSF21—prostate cancer	3.23e-06	0.000109	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP7B1—prostate cancer	3.15e-06	0.000106	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTAP—prostate cancer	3.15e-06	0.000106	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—prostate cancer	3.09e-06	0.000104	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	3.08e-06	0.000104	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SRD5A1—prostate cancer	3.07e-06	0.000104	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SULT1E1—prostate cancer	3.07e-06	0.000104	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOA1—prostate cancer	3.05e-06	0.000103	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.98e-06	0.000101	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TST—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADI1—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CBR1—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CSAD—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSAT1—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GRHL1—prostate cancer	2.94e-06	9.91e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.93e-06	9.91e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AR—prostate cancer	2.93e-06	9.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACSL4—prostate cancer	2.93e-06	9.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD17B3—prostate cancer	2.93e-06	9.88e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RXRA—prostate cancer	2.9e-06	9.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.89e-06	9.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PHGDH—prostate cancer	2.8e-06	9.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ARG2—prostate cancer	2.8e-06	9.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UMPS—prostate cancer	2.8e-06	9.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.79e-06	9.42e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LDHB—prostate cancer	2.75e-06	9.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGT2B15—prostate cancer	2.73e-06	9.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGT2B17—prostate cancer	2.73e-06	9.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GRHPR—prostate cancer	2.73e-06	9.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CKMT2—prostate cancer	2.73e-06	9.22e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP3A5—prostate cancer	2.7e-06	9.12e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SIRT1—prostate cancer	2.67e-06	9.01e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—prostate cancer	2.63e-06	8.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PDHA1—prostate cancer	2.61e-06	8.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UCP3—prostate cancer	2.61e-06	8.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TCN2—prostate cancer	2.61e-06	8.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA3—prostate cancer	2.61e-06	8.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RFK—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MBTPS1—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAGLU—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PGAM2—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM3—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SULT2B1—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AOX1—prostate cancer	2.57e-06	8.67e-05	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—prostate cancer	2.53e-06	8.56e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC22A3—prostate cancer	2.49e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD3B1—prostate cancer	2.49e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAT1—prostate cancer	2.43e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DEGS1—prostate cancer	2.43e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AMACR—prostate cancer	2.43e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SRD5A2—prostate cancer	2.43e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP3A43—prostate cancer	2.43e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.41e-06	8.15e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ERCC2—prostate cancer	2.41e-06	8.12e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TBXAS1—prostate cancer	2.38e-06	8.05e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA4—prostate cancer	2.38e-06	8.05e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.33e-06	7.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA2—prostate cancer	2.32e-06	7.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD17B1—prostate cancer	2.32e-06	7.84e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SULT1A1—prostate cancer	2.3e-06	7.75e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG5—prostate cancer	2.3e-06	7.75e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA1—prostate cancer	2.24e-06	7.57e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARA—prostate cancer	2.22e-06	7.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTO1—prostate cancer	2.22e-06	7.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD3B2—prostate cancer	2.22e-06	7.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAT2—prostate cancer	2.22e-06	7.49e-05	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	2.17e-06	7.33e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.13e-06	7.2e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLCB2—prostate cancer	2.13e-06	7.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LRP2—prostate cancer	2.13e-06	7.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2C18—prostate cancer	2.13e-06	7.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—P4HB—prostate cancer	2.08e-06	7.04e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPGD—prostate cancer	2.07e-06	6.99e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—B4GALT4—prostate cancer	2.07e-06	6.99e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC22A1—prostate cancer	2.03e-06	6.85e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—prostate cancer	2.01e-06	6.79e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2e-06	6.77e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SULT2A1—prostate cancer	1.98e-06	6.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.95e-06	6.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MED12—prostate cancer	1.94e-06	6.56e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNG5—prostate cancer	1.93e-06	6.51e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTAP—prostate cancer	1.89e-06	6.39e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.89e-06	6.39e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA3—prostate cancer	1.86e-06	6.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.84e-06	6.23e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.84e-06	6.23e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.83e-06	6.16e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPGDS—prostate cancer	1.77e-06	5.98e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CREBBP—prostate cancer	1.76e-06	5.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACSL4—prostate cancer	1.76e-06	5.94e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.76e-06	5.94e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACHE—prostate cancer	1.72e-06	5.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—prostate cancer	1.72e-06	5.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2A6—prostate cancer	1.7e-06	5.74e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.69e-06	5.71e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ARG2—prostate cancer	1.69e-06	5.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PHGDH—prostate cancer	1.69e-06	5.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UMPS—prostate cancer	1.69e-06	5.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LDHB—prostate cancer	1.65e-06	5.58e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKR1C3—prostate cancer	1.65e-06	5.58e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—prostate cancer	1.65e-06	5.58e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PRKACB—prostate cancer	1.64e-06	5.55e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP17A1—prostate cancer	1.63e-06	5.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.62e-06	5.48e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.6e-06	5.42e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UCP3—prostate cancer	1.57e-06	5.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TCN2—prostate cancer	1.57e-06	5.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA3—prostate cancer	1.57e-06	5.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PDHA1—prostate cancer	1.57e-06	5.29e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA2—prostate cancer	1.55e-06	5.24e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.5e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.5e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A5—prostate cancer	1.48e-06	4.99e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2E1—prostate cancer	1.44e-06	4.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.43e-06	4.84e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA4—prostate cancer	1.43e-06	4.84e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NQO1—prostate cancer	1.43e-06	4.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TH—prostate cancer	1.41e-06	4.75e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.4e-06	4.72e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA2—prostate cancer	1.4e-06	4.72e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.39e-06	4.7e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.39e-06	4.68e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG5—prostate cancer	1.38e-06	4.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.38e-06	4.66e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.37e-06	4.62e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA1—prostate cancer	1.35e-06	4.55e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.33e-06	4.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTO1—prostate cancer	1.33e-06	4.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAT2—prostate cancer	1.33e-06	4.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GGT1—prostate cancer	1.33e-06	4.48e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA1—prostate cancer	1.31e-06	4.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.29e-06	4.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLCB2—prostate cancer	1.28e-06	4.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.28e-06	4.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LRP2—prostate cancer	1.28e-06	4.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—P4HB—prostate cancer	1.25e-06	4.23e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RXRA—prostate cancer	1.24e-06	4.2e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.22e-06	4.12e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.21e-06	4.08e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COMT—prostate cancer	1.2e-06	4.04e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—prostate cancer	1.19e-06	4.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.19e-06	4.01e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ITPR1—prostate cancer	1.17e-06	3.96e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MED12—prostate cancer	1.17e-06	3.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNG5—prostate cancer	1.16e-06	3.92e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.15e-06	3.89e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA3—prostate cancer	1.12e-06	3.77e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—prostate cancer	1.11e-06	3.74e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—prostate cancer	1.09e-06	3.7e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LPL—prostate cancer	1.07e-06	3.63e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPGDS—prostate cancer	1.07e-06	3.6e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.06e-06	3.58e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—prostate cancer	1.05e-06	3.53e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.04e-06	3.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—prostate cancer	1.03e-06	3.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACHE—prostate cancer	1.03e-06	3.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ERCC2—prostate cancer	1.03e-06	3.48e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.02e-06	3.45e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKR1C3—prostate cancer	9.94e-07	3.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PRKACB—prostate cancer	9.89e-07	3.34e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.79e-07	3.3e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—prostate cancer	9.68e-07	3.27e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARA—prostate cancer	9.49e-07	3.21e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA2—prostate cancer	9.32e-07	3.15e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAV1—prostate cancer	8.93e-07	3.01e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A5—prostate cancer	8.9e-07	3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.69e-07	2.93e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NQO1—prostate cancer	8.59e-07	2.9e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.53e-07	2.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TH—prostate cancer	8.47e-07	2.86e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.24e-07	2.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.13e-07	2.75e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GGT1—prostate cancer	7.98e-07	2.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA1—prostate cancer	7.86e-07	2.65e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.74e-07	2.61e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—INS—prostate cancer	7.7e-07	2.6e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CREBBP—prostate cancer	7.54e-07	2.55e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RXRA—prostate cancer	7.47e-07	2.52e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—prostate cancer	7.25e-07	2.45e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COMT—prostate cancer	7.2e-07	2.43e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—prostate cancer	7.17e-07	2.42e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.15e-07	2.41e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ITPR1—prostate cancer	7.05e-07	2.38e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—prostate cancer	6.75e-07	2.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—prostate cancer	6.66e-07	2.25e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—prostate cancer	6.58e-07	2.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LPL—prostate cancer	6.46e-07	2.18e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.24e-07	2.11e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.23e-07	2.1e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ERCC2—prostate cancer	6.19e-07	2.09e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—prostate cancer	6.17e-07	2.08e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—prostate cancer	5.82e-07	1.96e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARA—prostate cancer	5.71e-07	1.93e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—prostate cancer	5.38e-07	1.82e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAV1—prostate cancer	5.37e-07	1.81e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—EP300—prostate cancer	5.13e-07	1.73e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.89e-07	1.65e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—INS—prostate cancer	4.63e-07	1.56e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CREBBP—prostate cancer	4.53e-07	1.53e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.3e-07	1.45e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—prostate cancer	4.06e-07	1.37e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.8e-07	1.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.75e-07	1.26e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—prostate cancer	3.71e-07	1.25e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—prostate cancer	3.24e-07	1.09e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—prostate cancer	3.1e-07	1.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EP300—prostate cancer	3.09e-07	1.04e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.28e-07	7.71e-06	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—prostate cancer	1.87e-07	6.3e-06	CbGpPWpGaD
